Kong Garheng

10% owner at American Oncology Network, Inc. · on record since Nov 9, 2023
Director at MELINTA THERAPEUTICS, INC. /NEW/ · on record since Mar 22, 2012
Director at ALIMERA SCIENCES INC · on record since Oct 4, 2012
10% owner at ALIMERA SCIENCES INC · on record since Oct 4, 2012
Director at LABCORP HOLDINGS INC. · on record since Dec 4, 2013
Director at Ocugen, Inc. · on record since Dec 2, 2014
Director at Strongbridge Biopharma plc · on record since Jan 2, 2018
Director at AVEDRO INC · on record since Feb 19, 2019
10% owner at AVEDRO INC · on record since Feb 13, 2019
10% owner at CASTLE BIOSCIENCES INC · on record since Jul 31, 2019
10% owner at Venus Concept Inc. · on record since Nov 7, 2019
See Remarks at CASTLE BIOSCIENCES INC · on record since May 19, 2020
Director at Xeris Biopharma Holdings, Inc. · on record since Jun 5, 2026
Director at Venus Concept Inc. · on record since Nov 7, 2019

Insider trading activity of Kong Garheng

Transactions on record: 137; since Mar 22, 2012

Open-market buys: 4; $5M

Open-market sells: 5; $9.4M

Companies traded: 9; last filing Jun 5, 2026

Figures computed from official regulatory filings — .

Companies where Kong Garheng has traded

Xeris Biopharma Holdings, Inc.21 tx · $249.5K · Jun 5, 2026
LABCORP HOLDINGS INC.40 tx · Feb 13, 2026
15 tx · $10.7M · Mar 28, 2023
12 tx · Jan 6, 2023
9 tx · $136.2K · Oct 6, 2021
15 tx · $11.5M · May 19, 2020
12 tx · $2M · Nov 26, 2019
4 tx · Jun 19, 2018
9 tx · $49.3K · Jun 14, 2018

Track record of Kong Garheng

Open-market buys: 7

Last buy: Nov 18, 2022

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of Kong Garheng

Co-insiders of Kong Garheng

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	Award	24,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	32,996	6.15 USD	$202.9K	Unusual size	SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2026	ExerciseD (derivative)	-897	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2026	Exercise	897	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 12, 2026	AwardD (derivative)	773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 4, 2025	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2025	AwardD (derivative)	897	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 10, 2025	ExerciseD (derivative)	-944	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 10, 2025	Exercise	944	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2024	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Apr 1, 2024	Other	6,474	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	Exercise	947	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	AwardD (derivative)	944	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	ExerciseD (derivative)	-947	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 7, 2023	Award	42,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Mar 28, 2023	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 14, 2023	ExerciseD (derivative)	-742	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 14, 2023	Exercise	742	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 9, 2023	AwardD (derivative)	849	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALIMERA SCIENCES INCListing unverified	Jan 6, 2023	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Nov 22, 2022	BuyD (derivative)	335,000	2.00 USD	$670K	Cluster	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 9, 2022	Award	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Mar 28, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 15, 2022	AwardD (derivative)	742	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	Award	24,193	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2026	AwardD (derivative)	32,996	6.15 USD	$202.9K	Unusual size	SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2026	ExerciseD (derivative)	-897	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2026	Exercise	897	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 12, 2026	AwardD (derivative)	773	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 4, 2025	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 13, 2025	AwardD (derivative)	897	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 10, 2025	ExerciseD (derivative)	-944	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 10, 2025	Exercise	944	—	n/a (No price was disclosed in the filing)		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 5, 2024	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Apr 1, 2024	Other	6,474	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	Exercise	947	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	AwardD (derivative)	944	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 8, 2024	ExerciseD (derivative)	-947	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 7, 2023	Award	42,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Mar 28, 2023	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 14, 2023	ExerciseD (derivative)	-742	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 14, 2023	Exercise	742	—	n/a (No price was disclosed in the filing)		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 9, 2023	AwardD (derivative)	849	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ALIMERA SCIENCES INCListing unverified	Jan 6, 2023	AwardD (derivative)	6,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Nov 22, 2022	BuyD (derivative)	335,000	2.00 USD	$670K	Cluster	SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Xeris Biopharma Holdings, Inc.Listing unverified	Jun 9, 2022	Award	15,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Venus Concept Inc.Listing unverified	Mar 28, 2022	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LABCORP HOLDINGS INC.Listing on record	Feb 15, 2022	AwardD (derivative)	742	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC